Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Bone Marrow Transplantation
|
June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis
Nadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Cell Host & Microbe
|
July 31, 2018
A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection
Amanda Jacobson, Lilian Lam, Manohary Rajendram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis
Taxiarchis V Kourelis, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
Yi L Hwa, Qian Shi, Shaji K Kumar, et al.
Ophthalmology
|
August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
Albert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Haematologica
|
August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
American Journal of Hematology
|
July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Marcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
Blood
|
October 13, 2016
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
Eli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
American Journal of Hematology
|
December 17, 2019
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity
Marcella Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Bone Marrow Transplantation
|
June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis
Nadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Cell Host & Microbe
|
July 31, 2018
A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection
Amanda Jacobson, Lilian Lam, Manohary Rajendram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis
Taxiarchis V Kourelis, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
Yi L Hwa, Qian Shi, Shaji K Kumar, et al.
Ophthalmology
|
August 25, 2019
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
Albert M Maguire, Stephen Russell, Jennifer A Wellman, et al.
Haematologica
|
August 2, 2016
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Eli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
American Journal of Hematology
|
July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein
Marcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.
Blood
|
October 13, 2016
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
Eli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
American Journal of Hematology
|
December 17, 2019
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity
Marcella Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Page
of 10